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Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF), a tick-borne disease caused by Crimean-Congo
hemorrhagic fever virus (CCHFV), is a member of the genus Nairovirus in the family Bunyaviridae. Recently, CCHFV
has been reported as an important emerging infectious viral pathogen in Sudan. Sporadic cases and multiple CCHF
outbreaks, associated with nosocomial chain of transmission, have been reported in the Kordufan region of Sudan.
Aims: To confirm CCHF in an index patient and attending physician in North Kordufan region, Sudan, and to
provide some information on virus genetic lineages.
Methods: Antibody captured ELISA, reverse transcription PCR, partial S segment sequences of the virus and
subsequent phylogenetic analysis were used to confirm the CCHFV infection and to determine the virus genetic
lineages.
Results: CCHF was confirmed by monitoring specific IgM antibody and by detection of the viral genome using RT-
PCR. Treatment with oral ribavirin, replacement with fluid therapy, blood transfusion and administration of platelets
concentrate resulted in rapid improvement of the health condition of the female physician. Phylogenetic analysis
of the partial S segment sequences of the 2 CCHFV indicates that both strains are identical and belong to Group III
virus lineage, which includes viruses from Africa including, Sudan, Mauritania, South Africa and Nigeria.
Conclusion: Further epidemiologic studies including, CCHFV complete genome analysis and implementation of
improved surveillance are urgently needed to better predict and respond to CCHF outbreaks in the Kordufan
region, Sudan.
Introduction
Crimean-Congo hemorrhagic fever (CCHF), caused by
Crimean-Congo hemorrhagic fever virus (CCHFV), is a
viral zoonotic disease with a high mortality rate in
humans. CCHFV can be transmitted to humans by bites
of Ixodid ticks or by contact with blood, bodily fluids or
tissue from viraemic livestock and infected humans [1].
CCHFV is one of the rare hemorrhagic fever viruses
capable of inducing nosocomial outbreaks in hospitals
with resource-poor setting and person to person
transmission is not uncommon [2,3]. CCHF is a public
health problem in many regions of the world including
the Sudan [4-13]. In remote areas and rural hospitals of
Kordufan, Sudan, diagnosis of the disease is primarily
based on clinical presentation. The laboratory diagnosis
of CCHF includes the serological tests for the detection
of immunoglobulin M and immunoglobulin G antibo-
dies and molecular-based technique such as conven-
tional and real-time RT-PCR for detection of the viral
genome [5,14,15].
In the past few years, CCHFV has been reported as an
important emerging infectious viral pathogen in Sudan.
We reported on nosocomial outbreak of CCHF in
Alfulah Rural Hospital, West Kordufan. Two virus
strains designated Al-fulah 3 and 4 (GenBank accession
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the nosocomial outbreak [4]. We have also reported on
an outbreak in Donkup village, Abyei District, South
Kordufan [5]. Despite the fact that the Alfulah and
Abyei strains belong to group III genetic lineage of
CCHFV they are genetically distinct from each other
and were identified as unique strains of the Sudanese
CCHFV. Abyei and Alfulah virus strains are considered
to be responsible for the emergence of the disease in
Western and Southern region of Kordufan [4,5]. How-
ever, CCHF has never been reported in North Kordufan.
In February, 2010, an index patient from Lagawa Dis-
trict, Southern Kordufan, Sudan, was admitted to
Lagawa Rural Hospital, with an acute hemorrhagic ill-
ness. Lagawa District is approximately 50 Kilometers
from Alfulah, the origin of the first CCHF outbreak in
Sudan. The index patient is a 60-years-old male who
was admitted with clinical presentation of an acute feb-
rile hemorrhagic illness. The symptoms included rapid
onset of fever, headache, nausea, vomiting of blood, and
bloody diarrhea. The source of infection was suspected
to have been the result of consumption of raw liver of
an infected sheep. He complained of high grade fever,
chills, headache, epistaxis, vomiting of blood and bloody
diarrhea. He had taken anti-malarial medication at
home without improvement. The patient was then
transferred to Kadogli Hospital, the referral hospital for
the State of Southern Kordufan, approximately 200 kilo-
meters from Lagawa District. As the medical facilities in
Kadogli Hospital are limited, his health condition dete-
riorated very rapidly and thus the patient sought addi-
tional health care at Elobied Hospital, the capital of
North Kordufan State. At Elobied Hospital, the patient
was subjected to medical examination by the attending
physician on Saturday, 20/02/2010 and was provided
medical care by nurse. Clinical investigations were con-
ducted and blood samples were collected after which
the patient was referred to Khartoum for further medi-
cal care. The patient was taken care of at the hospital
a n dh es u r v i v e dt h ei n f e c t i o na n dd i s c h a r g e df r o mt h e
hospital in a good health.
On Tuesday, 23/02/2010, the attending physician
developed high grade fever, backache, vertigo and she
became hypoglycemic. She received medical care and
nursing by her mother and sister. A few days later, her
sister had onset of a disease which did not progress
beyond mild fever. Blood films from the index patient
and the physician were malaria positive with high parasi-
temia. Treatment with an antimalarial drug did not result
in any improvement. Thus, the attending physician was
isolated and strict barrier nursing was implemented on
the suspicion of viral hemorrhagic fever (VHF). On
Saturday 27/02/2010, the health condition of the physi-
cian deteriorated very rapidly and she developed massive
vaginal bleeding, which lasted after 12 days. She also
developed renal insufficiency. The serum urea and creati-
nine levels were as high as 135 mg/dL and 13 mg/dL,
respectively. Blood platelets count was as low as 9 x10
3/
μl. Treatment with oral ribavirin at a dose rate of 500 mg
4 times a day for 5 days, compensation with four vials of
blood and administration of platelets concentrate
resulted in rapid improvement of her health condition
one week later. The blood platelets counts increased dra-
matically to 169 × 10
3 /μl. She was discharged from the
hospital on Tuesday 16/3/2010 in a good health condi-
tion with platelets count of 252 × 10
3 /μl.
In the present investigation, we report on a nosoco-
mial transmission of CCHF to an attending physician in
North Kordufan as a result of medical referral of an
infected patient, who is resident of Lagawa District,
South Kordufan. Rapid diagnosis allows proper manage-
ment of the disease during outbreak settings. In addi-
tion, molecular characterization of the virus provides
information on the virus genetic lineages, which subse-
quently provides a more detailed understanding of the
movement of virus strains in Kordufan region and in
Sudan at large [4].
Materials and methods
Crimean Congo hemorrhagic fever Case Definition
The case definition used for identification of Crimean
Congo hemorrhagic fever patients included hemorrhagic
manifestations (ecchymosis, petechia, epistaxis, hema-
temesis, and hemorrhagic enteritis as reflected by bloody
diarrhoea), and one or more of the following symptoms:
Fever, severe headache, joint pain, chills, and nausea.
Ethical clearance and informed consent
Blood samples were collected from the two acute
hemorrhagic fever (HF) patients in clean, sterile vacutai-
ners. Samples were collected as part of routine diagnos-
tic testing. Ethical clearance was obtained from the
Ministry of Health of Sudan and informed consent from
all patients was provided through an ethical clearance
form, which permitted use of the samples for diagnostic
and research purposes. In addition to being used for
routine malaria screening, blood was allowed to clot,
and sera were separated and sent to the Division of Vir-
ology, National Medical Health Laboratory, Khartoum,
Sudan, for serological diagnostic screening. Extracted
RNAs from serum samples were provided to the Mole-
cular Biology Laboratory, Faculty of Veterinary Medi-
cine, University of Khartoum for conventional RT-PCR
amplification and subsequent sequencing.
Serology and Molecular Diagnostic
Virus isolation attempts were not conducted as the cul-
tivation of CCHFV requires high laboratory
Elata et al. Virology Journal 2011, 8:303
http://www.virologyj.com/content/8/1/303
Page 2 of 7containments (biosafety level 4), a facility which is
restricted to a few laboratories in Africa. Therefore,
identification of the virus was solely dependent on serol-
ogy and conventional RT-PCR amplification, using pri-
mers targeting the S segment of the Al-fulah strain of
CCHFV (Genbank accession number GQ862371), fol-
lowed by direct sequencing of the PCR ampilicon. Sero-
logic tests were conducted to screen the sera for
CCHFV antibodies as determined by detection of IgM
using antibody capture enzyme-linked immunosorbent
assay (ELISA) kits from Biological Diagnostic Supplies
Limited (South Africa).
Design of primers
It is well documented that CCHFV small (S) RNA gen-
ome segment, which codes for viral nucleoprotein (NP)
and non-structural protein, has the less variable nucleo-
tide sequences among cognate genes of CCHFV strains
[16]. Thus, selection of the primers was based on a
highly conserved fragment of the S RNA segment of
Sudan, Alfulah-4 strain (GenBank accession number
GQ862371). The primers were designed based on multi-
ple sequence alignment of several published sequences
o ft h eg e n eu s i n gB i o E i d i ts o f t w a r e( C a r l s b a d ,C A ,
USA). A forward primer CCHF1 (5): CTG CTC TGG
TGG AGG CAA CAA (3) and a reverse primer CCHF2
(5): TGG GTT GAA GGC CAT GAT GTA T (3) were
used to amplify a 452-bp primary PCR product. An
internal pair of forward primer CCHFn1 (5): AGG TTT
CCG TGT CAA TGC AAA (3) and a reverse primer
CCHFn2 (5): TTG ACA AAC TCC CTG CAC CAG T
(3) were used to amplify a 207-bp nested PCR product.
Reverse transcription (RT) Polymerase chain reaction (RT-
PCR) amplification
A single-tube RT-PCR assay was carried out for CCHFV
RNAs amplification basically as described previously
[17]. Briefly, a standard 50 μl reaction mixture contained
in final concentration of 1 × enzyme mix reaction buf-
fer, 5.0 μlo f1 0m Md N T Pm i x ,5 . 0μlo f2 5m MM g
Cl2,5 . 0Ue n z y m em i x ,2 . 0μlo f2 0p i c o m o l eo fe a c h
primers (CCHF1 and CCHF2), 5.0 μlo ft a r g e tR N A ,
were used. The total volume was brought to 50.0 μl
using RNase free water. Target genes were amplified in
low-profile 0.2 ml tube (MJ Research, California, USA).
Rift Valley fever virus (RVFV) and Dengue virus RNA
templates were used as negative controls. Thermal pro-
files were performed on a Techne PHC-2 thermal cycler
(Techne, Princeton, NJ). The thermal cycling profiles
were started with 30-min incubation at 50°C for reverse
transcription of the CCHFV RNA templates into cDNA
copies. The PCR tubes were then incubated at 95°C for
15 min to destroy the excess amount of RT enzyme and
to activate the Taq DNA polymerase. The synthesized
cDNA copies in the PCR tubes were subjected to 40
cycles of denaturation at 95°C for 1 min, annealing at
56°C for 30 sec and extension at 72°C for 45 sec, and a
final incubation at 72°C for 10 min.
Nested RT-PCR amplification
For nested amplification, reaction mixtures similar to
those of RT-PCR were used, except that 2 μlo ft h ep r i -
mary PCR products were used as a template DNA for
PCR amplification. The thermal cycling profiles were
started with an initial denaturation at 95°C for 5-min,
and the PCR tubes were subjected to 40 cycles of dena-
turation at 95°C for 1 min, annealing at 56°C for 30 sec
and extension at 72°C for 45 sec, and a final incubation
at 72°C for 10 min. Following amplification, 10 μlf r o m
each PCR amplification product were loaded onto 2%
agarose gel and electrophoresed at 80 volts for 1 h. The
gels were stained with ethidium bromide, and a UV
light source was used to visualize the primary and the
nested PCR products.
Sequence analysis and phylogenetic relationship
The 452-bp primary PCR products were purified using
QIAquick PCR purification Kit (QIAgen, Germany) and
sent for sequencing in a commercial company (Seqlab,
Göttingen, Germany). Resulted sequences were edited
using BioEdit software and the Basic Local Alignment
Search Tool (BLAST) of NCBI (National Center for Bio-
technology Information, Bethesda, MD) and used to
confirm the identity of the generated sequences in the
GenBank nucleotide database. The sequences were then
aligned with the corresponding S-segment of known
CCHFV strains from Sudan, other African countries,
Asia, middle and far east, and Eastern Europe. Phyloge-
netic tree was constructed using PAUP version 4.0 soft-
ware packgae (Sinauer Associates, Inc., Sunderland, MA,
USA). The name of the virus strain, country of origin
and the GenBank accession numbers were given for
each sequence.
Results
Serologic studies
In the present study, serological attempts to diagnose
CCHF in acute phase sera sampled during the first 3
days post-infection (pi) from both patients were largely
unsuccessful. However, positive IgM antibodies to
CCHFV were detected in subsequent blood samples
drawn from the attending physician at day 7 pi.
Reverse-transcription (RT) polymerase chain reaction (RT-
PCR)
Application of the reverse transcriptase-polymerase
chain reaction (RT-PCR) assay, to acute phase sera
sampled during the first 3 days pi from both suspected
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bp PCR product (Figure 1). The second round of nested
RT-PCR amplification produced a 207 bp PCR product
specific for CCHFV S segment (Figure 2). No amplifica-
tion products were detected for RNAs from closely
related viral hemorrhagic fever viruses including Rift val-
ley fever virus (RVFV), Dengue virus, total nucleic acid
extracts from uninfected Vero cells, and sera from non-
infected patients (Figure 3).
Sequence analysis and phylogenetic relationship
The sequences from the primary 452-bp PCR products
were determined by BLAST/FASTA (http://www.ncbi.
nlm.nih.gov) and phylogenetic analysis. The sequences
were edited and assembled using Lasergene software
3 . 5 7( D N A S T A R ,M a d i s o n ,W I ,U S A ) .T h ep a r t i a lS -
segment of Lagawa strain showed 99% homology with
Sudan- Alfulah strain-3. Phylogenetic tree was con-
structed using PAUP version 4.0 software (Sinauer
Associates, Inc., Sunderland, MA, USA) to investigate
the relationship between Lagawa CCHFV strain and
other known CCHFV strains identified globally. The
phylogenetic analysis placed this virus strain in Group
III virus lineage, which includes virus strains from
across Africa including Sudan, Mauritania, South Africa
and Nigeria (Figure 4). The partial S-segment sequence
was submitted to the GenBank under accession number
HQ829854.
Discussion
Multiple Crimean-Congo hemorrhagic fever virus
(CCHFV) variants and strains, associated with CCHF
outbreaks, have recently been reported in Alfulah, Wes-
tern Kordufan [4] and in Abyei, Southern Kordufan of
Sudan [5]. However, CCHF has never been reported in
North Kordufan. In this study, a nosocomial transmis-
sion of CCHF has been reported in an attending physi-
cian in North Kordufan as a result of medical referral of
an infected patient from an endemic area in Lagawa
District, South Kordufan. In the present study, rapid
diagnosis of the disease was achieved using conventional
nested RT-PCR. The nested RT-PCR assay could be
used for detection of CCHFV in a simple laboratory set-
ting. In addition, the assay detected the multiple
CCHFV strains identified, so far, in Sudan. The first
RT-PCR round of amplification would be sufficient for
detection of CCHFV in sera sampled during acute phase
of the disease, as the titer of the virus is usually high
during this period, which allows for molecular charac-
terization studies without initial amplification of the
virus in cell culture. However, the second round of
nested amplification may only be required, at later stage
of the disease, when the concentration of the virus in
sera or tissue samples is very low. The well character-
ized primers designed from a highly conserved region of
the S-segment RNA would be expected to detect the
African CCHFV variants in group III virus lineage and
would probably detect the remaining CCHFV from
other virus lineages.
The source of the infection of the index patient was
considered to be the result of consumption of raw sheep
MW    1        2         3         4        5
1000 bp
500 bp
Figure 1 Visualization of the primary 452-bp CCHFV PCR
product on ethidium bromide-stained agarose gel from 1.0 pg
of RNA of Sudanese isolates of CCHFV variants. Lane MW:
molecular weight marker (100 bp DNA ladder); Lane 1: Alfulah strain
(positive control); Lane 2: Abyei strain; Lane 3-4: RNA extracted from
sera of the index patient and the attending physician (Lagawa
strains); Lane 5: RNA extracted from sera of healthy non infected
person.
500 bp
M W12 345
Figure 2 Visualization of the nested 207-bp PCR products from
the primary 452-bp PCR products
1000 bp
500 bp
MW 123 45
Figure 3 Specificity of the nested CCHFV RT-PCR for detection
of CCHFV RNA. Lane MW: molecular weight marker (100 bp DNA
ladder); Lane 1: Alfulah strain (positive control); Lane 2: RVFV RNA;
Lane 3: Dengue virus RNA; Lane 4-5: RNA extracted from sera of
healthy non infected persons.
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sumption of raw offals of cattle and raw livers of sheep
with bile and spices is not uncommon, which serves as
a means of transmission of various communicable dis-
eases [18] and CCHF is not an exception. It is note-
worthy that seasonality for CCHFV infection is quite
evident and usually coincides with the influx of sheep
from rural areas and villages to towns and major cities
on certain religious occasions [2]. Under these circum-
stances, the animal attendants typically live in close con-
tact with their animals. This will increase the risk of
acquiring CCHFV infection through direct contact with
infected animals or ticks.
Taking into consideration the identification of multi-
ple virus variants and strains in human cases from
Alfulah (2010) and Abyei districts of Kordufan region
(2011), in addition to the two CCHF cases mentioned in
the present study, it is likely that these CCHFV strains or
variants have been actively circulating in Western Sudan,
yet undetected for decades. In fact, sporadic cases and
outbreaks of acute febrile hemorrhagic illnesses compati-
ble with CCHF have long been observed in Kordufan
region for several past decades, but the virus was not
identified until very recently [4]. Given the fact that most
of CCHF sporadic cases and outbreaks occur in villages
and remote areas, together with combined unfamiliarity
of the Sudanese physicians with clinical signs and symp-
toms of CCHFV infections, iti sm o s tl i k e l yt h a tC C H F
cases can easily pass unreported or misdiagnosed. Cur-
rently, CCHF is not considered in the differential diagno-
sis of acute hemorrhagic illness in Sudan.
In Sudan, fever of unknown etiology is not uncom-
mon, but malaria is usually considered to be the pri-
mary cause [19]. The first line of treatment in the
hospitals focused primarily on prescription of anti-
malarial medication but without improvement. Find-
ings of this study illustrate that malaria positive result
does not necessarily eliminates the possibility of co-
infection with other viral hemorrhagic fever agents.
Interestingly enough, both patients were malaria posi-
tive as is the case with Alfulah and Abyei CCHF out-
breaks [4,5]. Currently we do not have an explanation
for the association of malaria and CCHF positive cases.
Therefore, physician should consider CCHF in their
differential diagnosis when dealing with malaria cases
in CCHF areas of endemicity.
Figure 4 Phylogenetic relationship of Sudan-Lagawa strains of CCHFV. Partial S segment sequences of the virus strains were aligned with
other CCHFV strains from Sudan, different African regions, the Middle and Far East, Asia, and Eastern Europe. Sequeces were analyzed with the
Lasergene 3.57 software package (DNASTAR, Madison, WI, USA). Phylogenetic tree was constructed using PAUP version 4.0 (Sinauer Associates,
Inc., Sunderland, MA, USA). Bootstrap values were calculated from analysis of 500 replicates of the data set, and values greater than 50% are
indicated at the appropriate nodes. Each CCHFV sequence is designated by the name of the strain, country of origin. The GenBank accession
numbers are given for each CCHFV isolate. The two Lagawa strains from Sudan (Sudan Lagawa1 and 2-2010) are highlighted in red color for
clarity (GenBank accession number (HG829854). Brace indicates group III virus genetic lineage (16).
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cases was due to CCHFV as determined by RT-PCR and
serology. Clearly, the disease is becoming endemic in
most areas of Kordufan region of Sudan. The two
CCHFV strains involved are identical and belonged to
group III virus lineage as determined by the S segment
partial sequences and subsequent phylogenetic analysis
[16]. The name Lagawa strain was initially proposed for
this CCHFV strain. The partial S segment sequence of
Lagawa strain, described in this study, shows 99%
homology to Alfulah strain (GenBank accession number
GQ862371) previously described by Aradaib et al., [4]. It
is suggested that whole genome of this CCHFV strain
be sequenced to obtain better information on the virus
and the possibility of genetic reassortment and/or
recombination events [8,20,21].
The CCHFV is susceptible to ribavirin in vitro but there
is no controlled study evaluating oral versus intravenous
ribavirin in treating infected patients. However, few studies
have evaluated oral ribavirin. Oral ribavirin, at a dose rate
of 200 mg twice daily for 5 days, is the recommended
dosage for post-exposure prophylaxis [22]. In the present
study, prescription of oral ribavirin, at a dose rate of 500
mg 4 times a day for 5 days, and administration of plate-
lets concentrate resulted in rapid improvement of the
health condition of the physician. Intravenous compensa-
tion with blood, platelets concentrate and fluid therapy
(dextrose and saline), augmented oral ribavirin therapy as
demonstrated by dramatic increase in blood platelets
counts. The treatment resulted in improved health condi-
tion of the female physician.
In conclusion, this study highlights the need to include
CCHF in the differential diagnosis, when fever with
hemorrhagic tendencies is observed in clinical centers
and hospitals in the Kordufan region, Sudan. The fre-
quent occurrence of sporadic cases and multiple CCHF
outbreaks, and the risks these cases pose for medical staff
in resource-poor health care facilities, necessitates the
need for improved surveillance programs and prevention
measures for this important viral disease in Sudan.
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